CD57high Neuroblastoma cells have aggressive attributes Ex situ and an undifferentiated phenotype in patients

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Schlitter, Anne Marie ^a   Dorneburg, Carmen ^a   Barth, Thomas F E ^a   Wahl, Joachim ^a   Schulte, Johannes H ^b   Brüderlein, Silke ^a   Debatin, Klaus Michael ^a   Beltinger, Christian ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL INVASION; CLONOGENESIS; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NEURAL CREST CELL; NEUROBLASTOMA CELL; NONHUMAN; PHENOTYPE;

ANIMALS; ANTIGENS, CD57; CELL ADHESION; CELL LINE, TUMOR; CELL LINEAGE; CELL MOVEMENT; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INTERMEDIATE FILAMENT PROTEINS; LIVER NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEUROGLIA; NEURONS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84865029244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042025     Document Type: Article

References (23)

1. Maris JM, Hogarty MD, Bagatell R, Cohn SL, (2007) Neuroblastoma. Lancet 369: 2106-2120.
2. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM, (1997) Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 16: 2985-2995.
3. Hansford LM, Thomas WD, Keating JM, Burkhart CA, Peaston AE, et al. (2004) Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification. Proc Natl Acad Sci U S A 101: 12664-12669.
4. Nakagawara A, Ohira M, (2004) Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model. Cancer Lett 204: 213-224.
5. Abo T, Balch CM, (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 127: 1024-1029.
6. Bronner-Fraser M, (1986) Analysis of the early stages of trunk neural crest migration in avian embryos using monoclonal antibody HNK-1. Dev Biol 115: 44-55.
7. Bronner-Fraser M, (1987) Perturbation of cranial neural crest migration by the HNK-1 antibody. Dev Biol 123: 321-331.
8. Hoehner JC, Hedborg F, Eriksson L, Sandstedt B, Grimelius L, et al. (1998) Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab Invest 78: 29-45.
9. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337.
10. Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, et al. (2007) Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 67: 11234-11243.
11. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
12. Ross RA, Spengler BA, (2007) Human neuroblastoma stem cells. Semin Cancer Biol 17: 241-247.
13. Tweddle DA, Malcolm AJ, Bown N, Pearson AD, Lunec J, (2001) Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res 61: 8-13.
14. Griffith LS, Schmitz B, Schachner M, (1992) L2/HNK-1 carbohydrate and protein-protein interactions mediate the homophilic binding of the neural adhesion molecule P0. J Neurosci Res 33: 639-648.
15. Cui H, Ma J, Ding J, Li T, Alam G, et al. (2006) Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. J Biol Chem 281: 34696-34704.
16. Cooper MJ, Steinberg SM, Chatten J, Evans AE, Israel MA, (1992) Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival. J Clin Invest 90: 2402-2408.
17. Thies A, Schachner M, Berger J, Moll I, Schulze HJ, et al. (2004) The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma. J Pathol 203: 933-939.
18. Hall H, Carbonetto S, Schachner M, (1997) L1/HNK-1 carbohydrate- and beta 1 integrin-dependent neural cell adhesion to laminin-1. J Neurochem 68: 544-553.
19. Hall H, Deutzmann R, Timpl R, Vaughan L, Schmitz B, et al. (1997) HNK-1 carbohydrate-mediated cell adhesion to laminin-1 is different from heparin-mediated and sulfatide-mediated cell adhesion. Eur J Biochem 246: 233-242.
20. Suzuki-Anekoji M, Suzuki M, Kobayashi T, Sato Y, Nakayama J, et al. HNK-1 glycan functions as a tumor suppressor for astrocytic tumor. J Biol Chem 286: 32824-32833.
21. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, et al. (1999) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86: 349-363.
22. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, et al. (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477.
23. Harms D, Wilke H, (1979) Grading procedures for neuroblastoma. Klin Padiatr 191: 228-233.